The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s brain tumor drugs market report forecasts the brain tumor drugs market size to grow to $4.74 Billion by 2027, with a CAGR (compound annual growth rate) of more than 6%.

Learn More On The Brain Tumor Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/brain-tumor-drugs-global-market-report

Brain Tumor Drugs Market Size Forecast
The global brain tumor drugs market is expected to grow from $3.49 billion in 2022 to $3.74 billion in 2023 at a compound annual growth rate (CAGR) of 7.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global brain tumor drugs market size is expected to grow to $4.74 billion in 2027 at a CAGR of 6.1%.

North America held the largest brain tumor drugs market share, and Middle East was the fastest-growing region in 2022.

Key Brain Tumor Drugs Market Driver ­– Increase In The Prevalence Of Neurological Disorders Worldwide
For example, as per the National Brain Tumor Society, around 700,000 people in the United States around 700,00 people are having a primary brain tumor, and around 86,000 more will be diagnosed. The increasing number of patients with neurological disorders including brain tumor is leading to a rise in the demand for the drugs used in their treatment.

Request for A Sample Of The Global Brain Tumor Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2588&type=smp

Key Brain Tumor Drugs Market Trend – Focusing On The Use Of Nanotechnology For Treatment
The nanoparticles are being used to carry drugs in combination, directly to the cancer cells or into the tumor. This technology has also led to a reduction in the dosage of the drugs, improved shelf life, and reduced toxicity. A few nanodrugs are proving to be useful in overcoming the blood-brain barrier, which was a significant challenge in the treatment of Brain tumors. For instance, Liposomes nanoparticles facilitate easy delivery of drugs to the core cancer cells, these particles if coated with transferrin can even pass through the blood-brain barrier. Companies including GE Healthcare, Sigma-Tau Pharmaceuticals Inc., Johnson & Johnson, Merck & Company Inc., Pfizer, Inc., and Celgene Corporation are adopting this technology to improve the available techniques of medication and treatment.

Brain Tumor Drugs Market Segment
1) By Type: Medulloblastoma, Astrocytoma, Oligodendroglioma, Primitive Neuroectodermal (PNET), Others (Glioma, Acoustic Neuroma, Meningioma)
2) By Drugs: Temozolomide, Carmustine, Cisplatin, Bevacizumab, Geftinib, Erlotinib
3) By End User: Hospital Pharmacies, Clinics, Other End-Users

Brain Tumor Drugs Market Major Players and Strategies
Major players in the brain tumor drugs market are Pfizer Inc., Shimadzu Corporation, Toshiba Medical Systems, Merck & Co. Inc., AstraZeneca, Carestream Health, Philips Healthcare, Siemens Healthineers, Hitachi Medical Corporation and GE Healthcare.

In December 2021, Sanofi, a France-based pharmaceutical company acquired Amunix Pharmaceuticals Inc. for a deal amount of $1 billion. Through this acquisition, Sanofi’s focus is on developing potentially transformative cancer therapies in immuno-oncology. Amunix Pharmaceuticals Inc. is a US-based pharmaceutical company that also includes brain tumor drugs.

The Brain Tumor Drugs Global Market Report 2023 covers regional data on brain tumor drugs market size, brain tumor drugs market trends and drivers, opportunities, strategies, and brain tumor drugs market competitor analysis. The countries covered in the brain tumor drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Brain tumor drugs refer to the drugs or medications that are used to treat brain tumor. Chemotherapy, hormone therapies, anticonvulsants, and painkillers are among the drugs used to treat brain tumours. While other prescription drugs are used to manage symptoms while the tumour is being treated, chemotherapy works to reduce or destroy brain tumours.

View More Reports Related To The Brain Tumor Drugs Market –
Tumor Embolization Devices Global Market Report 2023
Tumor Ablation Therapy Devices Global Market Report 2023
Cancer Tumor Profiling Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: